Artificial Intelligence in Drug Discovery Market to Hit US$ 3,547.4 Million by 2030: Coherent Market Insights
November 24, 2023 06:30 ET
|
CMI
Burlingame, Nov. 24, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, The global artificial intelligence in drug discovery market was valued at US$ 1,016.1Mn in 2022 and is forecast...
Celcuity to Participate in the 6th Annual Evercore ISI HealthCONx Conference
November 22, 2023 08:05 ET
|
Celcuity Inc.
MINNEAPOLIS, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced its...
Dyadic’s C1 Platform to be Used to Produce Vaccines for Humans and Animals in Africa
November 20, 2023 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ: DYAI), a global biotechnology company focused on building...
Polaris Group Initiates Rolling Submission of Biologic License Application (BLA) for ADI-PEG 20 with U.S. FDA to Treat Malignant Pleural Mesothelioma
November 16, 2023 19:49 ET
|
Polaris Group
TAIPEI, Taiwan and SAN DIGEO, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Polaris Group (The Company, TWSE:6550), today announced that the Company has initiated the rolling submission of its Biologic License...
Genome Editing Market revenue to hit USD 69.6 Billion by 2036, says Research Nester
November 14, 2023 05:30 ET
|
Research Nester
New York, Nov. 14, 2023 (GLOBE NEWSWIRE) -- The global genome editing market size is slated to expand at ~21.1% CAGR between 2024 and 2036. The market is poised to garner a revenue of USD 69.6...
MULTI-MILLION POUND BOOST FOR RESEARCH PROJECTS AIMED AT DEVELOPING NEW TESTS, TREATMENTS AND DEVICES FOR NEURODEGENERATIVE DISEASES
November 13, 2023 19:01 ET
|
LifeArc
MULTI-MILLION POUND BOOST FOR RESEARCH PROJECTS AIMED AT DEVELOPING NEW TESTS, TREATMENTS AND DEVICES FOR NEURODEGENERATIVE DISEASES Seven major research projects to receive more than £14 million to...
US Gastroenterologist Projections Suggest Significant Shift in Ulcerative Colitis Landscape Afoot, with Launches of Eli Lilly's Omvoh, Pfizer's Velsipity, Takeda's Subcutaneous Entyvio, and Celltrion's Zymfentra
November 13, 2023 09:22 ET
|
Spherix Global Insights
Exton, Pennsylvania, Nov. 13, 2023 (GLOBE NEWSWIRE) -- In the past two months, the landscape of available treatments for ulcerative colitis (UC) has undergone a significant expansion, marked by the...
Celcuity Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
November 13, 2023 07:05 ET
|
Celcuity Inc.
Received FDA clearance of IND to evaluate gedatolisib in combination with darolutamide in patients with metastatic castration resistant prostate cancer (mCRPC) Entered into a...
Cell and Gene Therapy Manufacturing Market to Achieve a Valuation of USD 8.8 billion by 2031| Analysis by Transparency Market Research
November 09, 2023 08:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global cell and gene therapy manufacturing market is projected to flourish at a CAGR of...
Global Precision Medicine Market Size Demonstrates Consistent Growth with a CAGR of 11.12%, with North America Taking a Leading Role
November 08, 2023 09:50 ET
|
Straits Research
New York, United States, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Precision medicine is a new approach to treating and preventing disease that considers each individual's genetic, environmental, and...